Monday 10 December, 2018
Edition: English (US)
MMJ Observer

22nd Century Group Inc (NYSEAMERICAN:XXII) will reap huge dividends from an FDA decree. According to the mandate of FDA, all cigarettes sold should have very levels of nicotine. 22nd Century has patents for cigarettes with low nicotine levels....

By Emily Gibson on Oct 24th, 2018

22nd Century Group Inc (NYSEAMERICAN:XXII) has appointed Juan Sanchez Tamburrino, Ph.D., as the firm’s VP of R&D. Dr. Tamburrino was formerly the head of the Plant Biotechnology Segment of British American Tobacco. The details In 2009,...

By Jaime Williams on Dec 6th, 2017

22nd Century Group Inc (NYSEAMERICAN:XXII) reported that the 2013 Research License & Commercial Option deal between the firm and British American Tobacco Limited is now completed. BAT no longer has any rights to any assets or intellectual...

By Brandon Manns on Oct 4th, 2017